RENAISSANCE TECHNOLOGIES LLC

Position in ONCY — Oncolytics Biotech Inc

CIK 1037389 NEW YORK, NY

Position in ONCY

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$58,909

-$549,553 QoQ

Shares Held

62,010

-91.3% QoQ

Ownership

0.049%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#18

of 74 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,952,579,858 across 312 Biotechnology names. ONCY ranks #285 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,427,993	$730,617,099
2	CORT	Corcept Therapeutics Inc	5,261,628	$457,498,554
3	INCY	Incyte Corp	3,512,132	$398,135,283
4	VRTX	Vertex Pharmaceuticals Inc / Ma	320,008	$158,957,573
5	JAZZ	Jazz Pharmaceuticals plc	562,073	$135,442,730
6	RPRX	Royalty Pharma plc	1,935,800	$108,540,306
7	TVTX	Travere Therapeutics, Inc.	1,833,079	$104,137,217
8	GMAB	Genmab A/S	3,517,850	$96,635,339

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$58,909	62,010	-91.3%	Shares	Sole	2026-08-13
2026-03-31	$608,462	715,838	+451.3%	Shares	Sole	2026-05-14
2023-03-31	$155,827	129,856	+15.3%	Shares	Sole	2023-05-12
2022-12-31	$183,538	112,600	+357.7%	Shares	Sole	2023-02-13
2022-09-30	$30,258	24,600	+75.7%	Shares	Sole	2022-11-14
2022-06-30	$14,140	14,000	-45.1%	Shares	Sole	2022-08-12
2022-03-31	$40,290	25,500	-89.2%	Shares	Sole	2022-05-13
2021-12-31	$327,314	235,478	+12.2%	Shares	Sole	2022-02-11
2021-09-30	$438,691	209,900	+812.6%	Shares	Sole	2021-11-12
2021-06-30	$63,710	23,000	-86.8%	Shares	Sole	2021-08-13
2020-12-31	$414,643	174,220	+1284.3%	Shares	Sole	2021-02-10
2020-09-30	$21,268	12,585	-70.0%	Shares	Sole	2020-11-13
2020-03-31	$57,958	41,999	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.